1. A letter of response to comments on 'A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers'. (April 2021) Authors: Dumont, Frédéric; Passot, Christophe; Raoul, Jean-Luc Journal: European journal of cancer Issue: Volume 147(2021) Page Start: 185 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers. (November 2020) Authors: Dumont, Frédéric; Passot, Christophe; Raoul, Jean-Luc; Kepenekian, Vahan; Lelièvre, Bénédicte; Boisdron-Celle, Michelle; Hiret, Sandrine; Senellart, Hélène; Pein, Francois; Blanc-Lapierre, Audrey; Raimbourg, Judith; Thibaudeau, Emilie; Glehen, Olivier Journal: European journal of cancer Issue: Volume 140(2020) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0394 SERUM CALPROTECTIN AS A PREDICTIVE MARKER OF THERAPEUTIC RESPONSE TO ADALIMUMAB IN RHEUMATOID ARTHRITIS. (June 2019) Authors: Servant, Guillaume; Passot, Christophe; Piver, Eric; Knight, Oscar; Devauchelle-Pensec, Valerie; Rist, Stéphanie; Perdriger, Aleth; Gervais, Elisabeth; Dernis, Emmanuelle; Goff, Benoit Le; Picon, Laurence; Goupille, Philippe; Mulleman, Denis Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 1657 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Antigenic burden and serum IgG concentrations influence rituximab pharmacokinetics in rheumatoid arthritis patients. (12th April 2017) Authors: Lioger, Bertrand; Edupuganti, Soujanya Ratna; Mulleman, Denis; Passot, Christophe; Desvignes, Céline; Bejan‐Angoulvant, Théodora; Thibault, Gilles; Gouilleux‐Gruart, Valérie; Mélet, Julien; Paintaud, Gilles; Ternant, David Journal: British journal of clinical pharmacology Issue: Volume 83:Number 8(2017) Page Start: 1773 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Development and validation of an ELISA to study panitumumab pharmacokinetics. (February 2018) Authors: Desvignes, Céline; Passot, Christophe; Ternant, David; Caulet, Morgane; Guérineau, Caroline; Lecomte, Thierry; Paintaud, Gilles Journal: Bioanalysis Issue: Volume 10:Number 4(2018) Page Start: 205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Development and validation of an enzyme-linked immunosorbent assay to measure free eculizumab concentration in serum. (August 2017) Authors: Passot, Christophe; Desvignes, Céline; Ternant, David; Bejan-Angoulvant, Theodora; Duveau, Anne-Claire; Gatault, Philippe; Paintaud, Gilles Journal: Bioanalysis Issue: Volume 9:Number 16(2017) Page Start: 1227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Feasibility and safety of tailored dosing schedule for eculizumab based on therapeutic drug monitoring: Lessons from a prospective multicentric study. Issue 5 (7th December 2020) Authors: Passot, Christophe; Sberro‐Soussan, Rebecca; Bertrand, Dominique; Caillard, Sophie; Schvartz, Betoul; Domenger, Camille; Contin‐Bordes, Cécile; Paintaud, Gilles; Halimi, Jean‐Michel; Ternant, David; Gatault, Philippe Journal: British journal of clinical pharmacology Issue: Volume 87:Issue 5(2021) Page Start: 2236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Phase I feasibility study for intrathecal administration of trastuzumab in patients with HER2 positive breast carcinomatous meningitis. (May 2018) Authors: Bonneau, Claire; Paintaud, Gilles; Trédan, Olivier; Dubot, Coraline; Desvignes, Céline; Dieras, Véronique; Taillibert, Sophie; Tresca, Patricia; Turbiez, Isabelle; Li, Jacques; Passot, Christophe; Mefti, Fawzia; Mouret-Fourme, Emmanuelle; Le Rhun, Emilie; Gutierrez, Maya Journal: European journal of cancer Issue: Volume 95(2018) Page Start: 75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Rationale for Therapeutic Drug Monitoring of Biopharmaceuticals in Inflammatory Diseases. Issue 4 (August 2017) Authors: Paintaud, Gilles; Passot, Christophe; Ternant, David; Bertolotto, Antonio; Bejan-Angoulvant, Theodora; Pascual-Salcedo, Dora; Mulleman, Denis Journal: Therapeutic drug monitoring Issue: Volume 39:Issue 4(2017:Aug.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The underlying inflammatory chronic disease influences infliximab pharmacokinetics. Issue 7 (2nd October 2016) Authors: Passot, Christophe; Mulleman, Denis; Bejan-Angoulvant, Theodora; Aubourg, Alexandre; Willot, Stephanie; Lecomte, Thierry; Picon, Laurence; Goupille, Philippe; Paintaud, Gilles; Ternant, David Journal: MAbs Issue: Volume 8:Issue 7(2016) Page Start: 1407 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗